New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Can-Fite Biopharma Ltd (CANF) vs Lantern Pharma Inc. (LTRN)
- Can-Fite Biopharma Ltd CANF 1.47 −2.65%
- Lantern Pharma Inc. LTRN 0.28 −15.15%
Can-Fite Biopharma Ltd and Lantern Pharma Inc. are both Biotechnology companies. Can-Fite Biopharma Ltd and Lantern Pharma Inc. are of similar size ($4.9M and $4.6M). Lantern Pharma Inc. has the higher net margin (0.00% vs −1,148.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Can-Fite Biopharma Ltd leads on 5 and Lantern Pharma Inc. on 5.
Valuation
Profitability
| Metric | CANF | LTRN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (1,148.62%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (250.59%) | (51.58%) |
| Return on assets | 0.00% | (124.41%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack